Clinical trial
Moderately Hypofractionated Micro-Boost Radiotherapy for Localized Prostate Cancer (62SPECIAL): an Observational Study
NCT07792993 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Moderately Hypofractionated Micro-Boost Radiotherapy for Localized Prostate Cancer (62SPECIAL): an Observational Study
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 7, 2025
- Completion date
- June 30, 2028
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
localized prostate cancer